QUESTION 114 License restrictions – contract includes multiple licenses Pharma licenses to Customer its patent rights to an approved drug compound for eight years beginning on January 1, 2010. Customer can only utilize the IP to sell products in the United States for the first year of the license. Customer can utilize the IP to sell products in Europe beginning on January 1, 2011. The contract does not include any other goods or services. Pharma concludes that the contract includes two distinct licenses: a right to use the IP in the United States and a right to use the IP in Europe. What is the impact of the contractual provisions that restrict the use of IP in this arrangement?